Hormone therapy does not affect depression severity in older women

被引:9
作者
Goldstein, KM [1 ]
Harpole, LH [1 ]
Stechuchak, KM [1 ]
Coffman, CJ [1 ]
Bosworth, HB [1 ]
Steffens, DC [1 ]
Bastian, LA [1 ]
机构
[1] Duke Univ, Ctr Hlth Serv Res Primary Care, Sch Med, Vet Adm Med Ctr,Med Ctr, Durham, NC 27705 USA
关键词
D O I
10.1176/appi.ajgp.13.7.616
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 [法学]; 0303 [社会学]; 100203 [老年医学];
摘要
Objective: Although estrogens are thought to have a beneficial effect on menopausal symptoms, the role of estrogen in the etiology and treatment of depression in older women remains unclear. The authors examined the relationship between hormone therapy ( HT) use and depressive symptom severity. Methods: Authors report the findings from a cross-sectional analysis of baseline data from the Improving Mood: Promoting Access to Collaborative Treatment ( IMPACT) Study, using data from 1,160 women age 60 years and older. Results: Women who were taking HT were likely to be younger, White, married, and to have had at least some college education. They were also more likely to report good or better health and to have taken antidepressant medications in the past 3 months. Although HT use was associated with more severe depressive symptoms in the unadjusted analysis, it was not associated with depression severity in adjusted analyses. Although there was a trend for a differential effect of college education with HT use on depression scores, no significant interaction was found between HT and race. Conclusion: There was no evidence to suggest that women HT users differ from non-HT users in depressive symptom severity.
引用
收藏
页码:616 / 623
页数:8
相关论文
共 38 条
[1]
Perceptions of menopausal stage and patterns of hormone replacement therapy use [J].
Bastian, LA ;
Couchman, GM ;
Rimer, BK ;
McBride, CM ;
Feaganes, JR ;
Siegler, IC .
JOURNAL OF WOMENS HEALTH, 1997, 6 (04) :467-475
[2]
Birkhäuser M, 2002, MATURITAS, V41, pS3
[3]
DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13
[4]
Derogatis LR, 1974, PSYCHOL MEASUREMENTS, P79
[5]
First S., 1995, BIOMETRICS RES DEP
[6]
Effect of postmenopausal hormone therapy on cognitive function: The heart and estrogen/progestin replacement study [J].
Grady, D ;
Yaffe, K ;
Kristof, M ;
Lin, F ;
Richards, C ;
Barrett-Connor, E .
AMERICAN JOURNAL OF MEDICINE, 2002, 113 (07) :543-548
[7]
A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease [J].
Grodstein, F ;
Manson, JE ;
Colditz, GA ;
Willett, WC ;
Speizer, FE ;
Stampfer, MJ .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (12) :933-941
[8]
Effects of estrogen plus progestin on health-related quality of life [J].
Hays, J ;
Ockene, JK ;
Brunner, RL ;
Kotchen, JM ;
Manson, JE ;
Patterson, RE ;
Aragaki, AK ;
Shumaker, SA ;
Brzyski, RG ;
LaCroix, AZ ;
Granek, IA ;
Valanis, BG .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (19) :1839-1854
[9]
Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy - Results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial [J].
Hlatky, MA ;
Boothroyd, D ;
Vittinghoff, E ;
Sharp, P ;
Whooley, MA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (05) :591-597
[10]
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women [J].
Hulley, S ;
Grady, D ;
Bush, T ;
Furberg, C ;
Herrington, D ;
Riggs, B ;
Vittinghoff, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07) :605-613